Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9952
Title: CNTO-328 (Centocor).
Austin Authors: Li, Jie;Hu, Xiu Feng;Xing, Pei Xiang
Affiliation: The Austin Research Institute, Kronheimer Building, Austin Health, Studley Road, Heidelberg 3084, Victoria, Australia
Issue Date: 1-Jun-2005
Publication information: Current Opinion in Investigational Drugs (london, England : 2000); 6(6): 639-45
Gov't Doc #: 15988916
URI: http://ahro.austin.org.au/austinjspui/handle/1/9952
URL: https://pubmed.ncbi.nlm.nih.gov/15988916
Type: Journal Article
Subjects: Animals
Antibodies, Monoclonal.adverse effects.pharmacokinetics.therapeutic use
Antineoplastic Agents.adverse effects.pharmacokinetics.therapeutic use
Clinical Trials as Topic
Humans
Interleukin-6.immunology
Neoplasms.drug therapy.metabolism
Appears in Collections:Journal articles

Show full item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.